Gilead Sciences, Inc : European Commission Approves Gilead s Trodelvy For Pre-Treated HR+/HER2- Metastatic Breast Cancer finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
We recently asked our audience of patients, survivors and caregivers about the ongoing cisplatin and carboplatin shortage. Here’s what they had to say.
Even with the increase of immunotherapy utilization to treat patients with advanced renal cell carcinoma, more research is needed to determine in which order to administer it as later lines of therapy.
Although the use of immunotherapy treatment approaches continues to become more prevalent in advanced renal cell carcinoma, high-level evidence showing benefit of sequential administration of these agents are limited.
The goal of the study was to compare outcomes in very-high-, high-, and low-risk NCCN groups as well as outcomes of CSCCs stratified by treatment with Mohs and wide local excision.